Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium. - Test2 - elhamkhani - TriplyDB

Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium.

Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium.

http://www.wikidata.org/entity/Q39077826

about

Exosome-associated AAV vector as a robust and convenient neuroscience tool The CB2 receptor and its role as a regulator of inflammation The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?Endocannabinoids in cerebrovascular regulation.Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function.Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.The endocannabinoid system in the baboon (Papio spp.) as a complex framework for developmental pharmacology.Chronic Δ(9)-Tetrahydrocannabinol Administration Reduces IgE(+)B Cells but Unlikely Enhances Pathogenic SIVmac251 Infection in Male Rhesus Macaques of Chinese Origin.Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

P2860

Q27323458-FABB6927-D762-4C8E-84F1-DDED136F05E6 Q28066700-CD9F39D1-A819-4031-A744-AC2D83394358 Q35992296-B67D840E-B8B0-486C-B83F-89B03CB52FE6 Q36789308-8CAD0EBE-8DD6-4810-B383-2F1A5B5B3157 Q36895795-29CD2E48-4C3A-49C2-ACFF-6D66CC774A08 Q37589006-1066D6F4-4578-42A8-A5B1-771D9A0D4EF7 Q38520997-0B2F1A8C-A1D6-46DC-B248-A355020770FC Q38684679-5260315E-0D7A-48D9-96C0-24AF2B4A9D35 Q39666956-2FA20FE7-2C9E-4718-A8E6-4308BAB30467 Q40701297-387BF5F1-0857-4CD6-A7C3-68B555E96D52 Q52689036-FED3ADB7-CEB0-40D0-A253-750768C63A7E

P2860

Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium.

http://www.wikidata.org/entity/Q39077826

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Activation of Cannabinoid Type ...... ophages and Brain Endothelium.

@en

Activation of Cannabinoid Type Two Receptors

@nl

type

label

Activation of Cannabinoid Type ...... ophages and Brain Endothelium.

@en

Activation of Cannabinoid Type Two Receptors

@nl

prefLabel

Activation of Cannabinoid Type ...... ophages and Brain Endothelium.

@en

Activation of Cannabinoid Type Two Receptors

@nl

P1433

Q39077826-118B132C-B342-4013-95B7-A794BA8EFE9C

P1476

Q39077826-0F0E178A-1145-4AE5-9CF7-4008A7BAF514

P2093

Q39077826-192E6D4A-8669-493B-BF5D-5CF2EF9F8BC0

Q39077826-29CB08EB-5CD3-4253-843D-C9F24B51E26E

Q39077826-6AC2F41E-772C-48F0-8561-2B8BF0DA6FE5

Q39077826-B96B26B8-BA44-419E-84FF-5175F46B8C3F

Q39077826-F529DD5B-BCEF-46DD-9EF1-F5FA52BF4AF8

Q39077826-F615CFEF-9150-43F2-87D0-55B3E462E20F

P2860

Q39077826-0AB06193-98DF-4545-A477-77A699C4569C

Q39077826-12583D9D-3E35-4835-A389-DCE858DC98A2

Q39077826-1A539C9E-C1D3-4FBD-9B47-E19A6B620398

Q39077826-29561F60-273C-4BF9-BEBB-0B534A748CD7

Q39077826-46EB7507-D930-4A11-9926-717723BB17BC

Q39077826-4B65635D-2A8D-4B7A-B889-657E2BFCF186

Q39077826-5C2E91B1-30EC-4568-9286-713811A29474

Q39077826-602ED247-53B2-4B47-8E72-09FD7C96164A

Q39077826-666BB6CC-BAD5-4830-8071-9ADA438BE175

Q39077826-69E739BE-0891-48C1-A044-FB8EB8669A42

P2888

Q39077826-28A04F74-92DD-4BA8-BFF9-E34276006B7D

P304

Q39077826-74DA7637-4E16-450C-8FE5-D7ED45215DA4

P31

Q39077826-DD06B721-486C-4037-992A-1899D92AA31A

P356

Q39077826-3EE05FCC-BC75-4E37-90DE-EE1DB424866A

P433

Q39077826-C8485649-AEE5-4F68-8952-9B7CF36F5D65

P478

Q39077826-9216A40C-4838-4FE6-9051-D435702E6783

P577

Q39077826-95E3DFC7-717A-4395-A46B-12CE63FAC885

P698

Q39077826-4B970E8A-3D02-45D7-93F1-B4804530D4C6

P921

Q39077826-70CB7F83-199C-4566-AB28-689F0D517FA2

Q39077826-7bcdeea0-30cb-43d2-b2f4-12f2beb19541

Q39077826-A8A3DC3C-34D1-4058-8806-5E274A497F2C

Q39077826-DD210435-ABA8-45E5-B6D9-7590FF3F9A3A

P932

Q39077826-AD427AA2-80C0-4998-99D4-B4F694915EFB

P356

S11481-015-9591-3

P1433

Journal of Neuroimmune Pharmacology

P1476

Activation of Cannabinoid Type ...... ophages and Brain Endothelium.

@en

P2093

Holly Dykstra

http://www.w3.org/2001/XMLSchema#string

Nancy L Reichenbach

http://www.w3.org/2001/XMLSchema#string

Servio H Ramirez

http://www.w3.org/2001/XMLSchema#string

Shongshan Fan

http://www.w3.org/2001/XMLSchema#string

Slava Rom

http://www.w3.org/2001/XMLSchema#string

Yuri Persidsky

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor

CROI 2014: Neurologic complications of HIV infection

Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood-brain barrier under physiologic and neuroinflammatory conditions.

Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells

Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.

Modulation of gut-specific mechanisms by chronic δ(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis.

HIV-1 neuroimmunity in the era of antiretroviral therapy.

Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis.

Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals

P2888

s11481-015-9591-3

P304

302-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11481-015-9591-3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25666933

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoid receptor

P932

4795159

http://www.w3.org/2001/XMLSchema#string